First-Line Lung Cancer Combinations: Are We Treating Better, or Simply Adding Drugs?

Authors

Telma Sequeira Respiratory Medicine Department, IPO de Lisboa Francisco Gentil, Lisbon, Portugal; Faculdade de Medicina Universidade de Lisboa, Lisbon, Portugal; Education Committee, International Association for the Study of Lung Cancer (IASLC) https://orcid.org/0000-0001-8031-7136

DOI:

https://doi.org/10.82582/thorac.135

Downloads

Download data is not yet available.

Downloads

PDF

Published

2026-08-18

Issue

Vol. 3 No. 1 (2026)

Section

Editorial

License

Copyright (c) 2026 Author(s) (or their employer(s)) and THORAC 2024

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Most read articles by the same author(s)

Manuel d'Almeida, Telma Sequeira, Ambrus Szantho, Jorge Dionísio, One Bronchus too Many: A Rare Bronchoscopy Finding , Thoracic Cancer Journal: Vol. 2 No. 2 (2025)
Sónia Silva, Telma Sequeira, Fernando Barata, New approaches in RET and MET in NSCLC , Thoracic Cancer Journal: Vol. 19 No. 2 (2022)
Filipa Simões, Telma Sequeira, Rita Rosa, Joana Desterro, Maria Teresa Almodovar, Alectinib-induced anemia with acanthocytosis: To proceed or discontinue treatment in Non-Small Cell Lung Cancer patients? , Thoracic Cancer Journal: Vol. 20 No. 2 (2023)
Raquel Paulinetti Camara, Kelly Lopes, Miguel Barbosa, Inês Sucena, Carla Simão, Paulo Mota, Dina Matias, Telma Sequeira, Teresa Almodovar, AT LAST! It was not a progression! , Thoracic Cancer Journal: Vol. 19 No. 1 (2022)